Enpp-1-IN-29
Enpp-1-IN-29 (Compound 1) is a highly selective ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor (IC50=0.05 nM) . Enpp-1-IN-29 is promising for research of ENPP1-overexpressing cancers (e.g., breast cancer, head/neck cancer, metastatic chromosome-unstable tumors) and immune-related diseases (e.g., autoimmune disorders, tumor immune evasion) [1].
Product Specifications
CAS Number
[2944114-41-2]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C1OCC2=CN=C3N=C(C=CC3=C2N1CC4=C(C=C(S(=O)(N)=O)C=C4F)F)OC
Molecular Formula
C18H14F2N4O5S
Molecular Weight
436.39
References & Citations
[1]Zhou FG, et al. Crystal form of enpp1 inhibitor. WO2024255837A1. 2024-12-19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Schizosaccharomyces pombe U1 small nuclear ribonucleoprotein usp102 (usp102)
Recombinant Schizosaccharomyces pombe U1 small nuclear ribonucleoprotein usp102 (usp102)
Recombinant Schizosaccharomyces pombe U1 small nuclear ribonucleoprotein usp102 (usp102)
Recombinant Schizosaccharomyces pombe U1 small nuclear ribonucleoprotein usp102 (usp102)
Recombinant Schizosaccharomyces pombe U1 small nuclear ribonucleoprotein usp102 (usp102)